Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Voglibose I.P. 0.3 Tablets
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹99/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Vogliviga 0.3 Tablet contains Voglibose 0.3mg, an alpha-glucosidase inhibitor used to control postprandial (after meal) blood sugar levels in patients with type 2 diabetes mellitus. It works by delaying the breakdown and absorption of complex carbohydrates in the small intestine, thereby reducing the rise in blood glucose after meals. This makes it an effective add-on therapy to diet, exercise, and other oral antidiabetic agents, especially for managing postprandial hyperglycemia.
Common side effects include flatulence, abdominal discomfort, bloating, and mild diarrhea. These effects usually subside as the body adjusts to the medication. Serious gastrointestinal effects are rare.
Indicated for type 2 diabetes mellitus patients, particularly for controlling post-meal blood sugar spikes in combination with other antidiabetic medications.
Not suitable for individuals with gastrointestinal disorders like inflammatory bowel disease, intestinal ulcers, or chronic digestive problems. Blood sugar levels should be monitored regularly. Use with caution in patients with liver or kidney impairment.
Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep out of the reach of children.
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 500mg Tablets
Composition : Dapagliflozin 10mg + Metformin Hydrochloride I.P. 1000mg Tablets
Composition : Dapagliflozin Propanediol Monohydrate 10mg + Vildagliptin I.P. 100mg Tablets
Composition : Metformin 1000mg (S.R.) Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Vogliviga 0.3 Tablet has strong demand in the anti-diabetic and metabolic care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on diabetology and chronic-care portfolios.
Medical distributors and agencies can benefit from consistent demand for management of type 2 diabetes mellitus and post-meal (postprandial) blood sugar control. Voglibose 0.3mg helps reduce absorption of carbohydrates and controls after-meal blood sugar spikes This supports better glycemic control and strengthens a reliable anti-diabetic portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Vogliviga 0.3 Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong diabetologist prescriptions, steady chronic-care demand, large diabetic patient base, reliable supply chain support, and good margins in anti-diabetic medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.